BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 34295757)

  • 1. Using the Movember Foundation's GAP3 cohort to measure the effect of active surveillance on patient-reported urinary and sexual function-a retrospective study in low-risk prostate cancer patients.
    Crump RT; Remmers S; Van Hemelrijck M; Helleman J; Nieboer D; Roobol MJ; Venderbos LDF;
    Transl Androl Urol; 2021 Jun; 10(6):2719-2727. PubMed ID: 34295757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Effects of Focal Therapy for Prostate Cancer on Sexual Function: A Combined Analysis of Three Prospective Trials.
    Yap T; Ahmed HU; Hindley RG; Guillaumier S; McCartan N; Dickinson L; Emberton M; Minhas S
    Eur Urol; 2016 May; 69(5):844-51. PubMed ID: 26525837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient-reported outcomes after buccal mucosal graft urethroplasty for bulbar urethral strictures: results of a prospective single-centre cohort study.
    D'hulst P; Muilwijk T; Vander Eeckt K; Van der Aa F; Joniau S
    BJU Int; 2020 Dec; 126(6):684-693. PubMed ID: 32512634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of self-estimation of disuric disorders gauged IPSS scale and qualities of lives QoL with self-estimation of sexual life gauged by IIEF-5 scale].
    Lipczyński W; Dobrowolska-Glazar B; Dobrowolski ZF
    Przegl Lek; 2012; 69(6):247-52. PubMed ID: 23094437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of repeated prostate biopsies on sexual function and urinary symptoms in patients with diagnosis of Atypical Small Acinar Proliferation (ASAP): can ecoDoppler reduce side effects?
    Quaresima L; Lacetera V; Leone L; Montesi L; Cantoro U; Polito M; Muzzonigro G
    Arch Ital Urol Androl; 2014 Dec; 86(4):356-8. PubMed ID: 25641471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Movember Foundation's GAP3 cohort: a profile of the largest global prostate cancer active surveillance database to date.
    Bruinsma SM; Zhang L; Roobol MJ; Bangma CH; Steyerberg EW; Nieboer D; Van Hemelrijck M;
    BJU Int; 2018 May; 121(5):737-744. PubMed ID: 29247473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validity of Erectile Function Assessment Questionnaires in Premature Ejaculation Patients: A Comparative Study Between the Abridged Forms of the International Index of Erectile Function and Proposal for Optimal Cutoff Redefinition.
    Xi Y; Colonnello E; Ma G; Limoncin E; Ciocca G; Zhang H; Jannini EA; Zhang Y
    J Sex Med; 2021 Mar; 18(3):440-447. PubMed ID: 33384239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient reported outcomes among treatment modalities for prostate cancer.
    Johnson ME; Zaorsky NG; Martin JM; Ruth K; Greenberg RE; Uzzo RG; Hayes SB; Smaldone MC; Kutikov A; Viterbo R; Chen DY; Hallman MA; Sobczak ML; Horwitz EM
    Can J Urol; 2016 Dec; 23(6):8535-8545. PubMed ID: 27995848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Focal therapy for localised unifocal and multifocal prostate cancer: a prospective development study.
    Ahmed HU; Hindley RG; Dickinson L; Freeman A; Kirkham AP; Sahu M; Scott R; Allen C; Van der Meulen J; Emberton M
    Lancet Oncol; 2012 Jun; 13(6):622-32. PubMed ID: 22512844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate cancer active surveillance and health-related quality of life: results of the Finnish arm of the prospective trial.
    Vasarainen H; Lokman U; Ruutu M; Taari K; Rannikko A
    BJU Int; 2012 Jun; 109(11):1614-9. PubMed ID: 22044485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of Return to Baseline Urinary and Sexual Function Following Primary Focal Cryotherapy for Nonmetastatic Prostate Cancer.
    Shah TT; Peters M; Miah S; Eldred-Evans D; Yap T; Hosking-Jervis F; Dudderidge T; Hindley RG; McCracken S; Greene D; Nigam R; Valerio M; Winkler M; Virdi J; Arya M; Ahmed HU; Minhas S
    Eur Urol Focus; 2021 Mar; 7(2):301-308. PubMed ID: 31590961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting Biopsy Outcomes During Active Surveillance for Prostate Cancer: External Validation of the Canary Prostate Active Surveillance Study Risk Calculators in Five Large Active Surveillance Cohorts.
    Drost FH; Nieboer D; Morgan TM; Carroll PR; Roobol MJ;
    Eur Urol; 2019 Nov; 76(5):693-702. PubMed ID: 31451332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term sexual outcomes after holmium laser enucleation of the prostate: which patients could benefit the most?
    Capogrosso P; Ventimiglia E; Ferrari M; Serino A; Boeri L; Capitanio U; Briganti A; Damiano R; Montorsi F; Salonia A
    Int J Impot Res; 2016 Sep; 28(5):189-93. PubMed ID: 27465782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consistent Biopsy Quality and Gleason Grading Within the Global Active Surveillance Global Action Plan 3 Initiative: A Prerequisite for Future Studies.
    van der Kwast TH; Helleman J; Nieboer D; Bruinsma SM; Roobol MJ; ; Trock B; Ehdaie B; Carroll P; Filson C; Kim J; Logothetis C; Morgan T; Klotz L; Pickles T; Hyndman E; Moore CM; Gnanapragasam V; Van Hemelrijck M; Dasgupta P; Bangma C; Roobol M; Villers A; Rannikko A; Valdagni R; Perry A; Hugosson J; Rubio-Briones J; Bjartell A; Hefermehl L; Shiong LL; Frydenberg M; Kakehi Y; Chung BH; van der Kwast T; Obbink H; van der Linden W; Hulsen T; de Jonge C; Kattan M; Xinge J; Muir K; Lophatananon A; Fahey M; Steyerberg E; Nieboer D; Zhang L; Guo W; Benfante N; Cowan J; Patil D; Tolosa E; Kim TK; Mamedov A; LaPointe V; Crump T; Kimberly-Duffell J; Santaolalla A; Nieboer D; Olivier JT; Rancati T; Ahlgren H; Mascarós J; Löfgren A; Lehmann K; Lin CH; Hirama H; Lee KS; Jenster G; Auvinen A; Bjartell A; Haider M; van Bochove K; Carter B; Gledhill S; Buzza M; Bangma C; Roobol M; Bruinsma S; Helleman J
    Eur Urol Oncol; 2019 May; 2(3):333-336. PubMed ID: 31200849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of the impact of sildenafil citrate on lower urinary tract symptoms in men with erectile dysfunction.
    Mulhall JP; Guhring P; Parker M; Hopps C
    J Sex Med; 2006 Jul; 3(4):662-667. PubMed ID: 16839322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adherence to Active Surveillance Protocols for Low-risk Prostate Cancer: Results of the Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance Initiative.
    Kalapara AA; Verbeek JFM; Nieboer D; Fahey M; Gnanapragasam V; Van Hemelrijck M; Lee LS; Bangma CH; Steyerberg EW; Harkin T; Helleman J; Roobol MJ; Frydenberg M;
    Eur Urol Oncol; 2020 Feb; 3(1):80-91. PubMed ID: 31564531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive correlation between the International Index of Erectile Function (IIEF) and Sexual Health Inventory for Men (SHIM): implications for calculating a derived SHIM for clinical use.
    Ramanathan R; Mulhall J; Rao S; Leung R; Martinez Salamanca JI; Mandhani A; Tewari A
    J Sex Med; 2007 Sep; 4(5):1336-44. PubMed ID: 17666037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serial prostate biopsies are associated with an increased risk of erectile dysfunction in men with prostate cancer on active surveillance.
    Fujita K; Landis P; McNeil BK; Pavlovich CP
    J Urol; 2009 Dec; 182(6):2664-9. PubMed ID: 19836757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Prostate Volume and Minimum Tumor Temperature on 4-Year Quality-of-Life After Focal Cryoablation Compared with Active Surveillance in Men with Prostate Cancer.
    Monaco A; Sommer J; Akerman M; Joshi P; Corcoran A; Katz A
    J Endourol; 2022 Dec; 36(12):1625-1631. PubMed ID: 36106598
    [No Abstract]   [Full Text] [Related]  

  • 20. Urinary symptom flare after brachytherapy for prostate cancer is associated with erectile dysfunction and more urinary symptoms before implantation.
    Lehrer S; Cesaretti J; Stone NN; Stock RG
    BJU Int; 2006 Nov; 98(5):979-81. PubMed ID: 17034599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.